Related Experiment Video
Updated: Jun 6, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Multimodal Fusion-Based Lightweight Model for Enhanced Generalization in Drug-Target Interaction Prediction
Jonghyun Lee1, Dokyoon Kim1, Dae Won Jun2,3
1Institute of Biomedical Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Abstract:
Predicting drug-target interactions (DTIs) with precision is a crucial challenge in the quest for efficient and cost-effective drug discovery. Existing DTI prediction models often require significant computational resources because of the intricate and exceptionally lengthy protein target sequences. This study introduces MMF-DTI, a lightweight model that uses multimodal fusion, to improve the generalizability of DTI predictions without sacrificing computational efficiency. The MMF-DTI model combines four distinct modalities: molecular sequence, molecular properties, target sequence, and target function description. This approach is noteworthy because it is the first to use natural language-based target function descriptions in predicting DTIs. The effectiveness of MMF-DTI has been confirmed through benchmark data sets, demonstrating its comparable performance in terms of generalizability, especially in scenarios with limited information about the drug or target. Remarkably, MMF-DTI accomplishes this using only half of the parameters and 17% of the VRAM compared with previous state-of-the-art models. This allows it to function even in constrained computational environments. The combination of performance and efficiency highlights the potential of multimodal data fusion in improving the overall applicability of models, providing promising opportunities for future drug discovery endeavors.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Quantitative Aspects of Drug-Receptor Interaction

